FDA-approved manufacturing plant opens in Sydney
- 05 August, 2009 15:59
- Comments
The Hon. Mr Simon Crean at the opening of the Parnell plant.
Veterinary pharmaceutical company, Parnell, today opened a $15 million 3,000 square metre manufacturing facility in Alexandria in Sydney.
The facility has been built to the high standards required by US and European regulators for the manufacture highly potent sterile injectables.
According to Parnell, it has the capacity to manufacture millions of doses of its Estroplan - a reproductive hormone for cattle - and Zyadax - a product which treats osteoarthritis in dogs and horses - medications annually, and has been designed to cater to significant global expansion and contract manufacturing possibilities.
The deal is expected to increase Parnell's annual sales to more than $80 million over the next five years.
The plant was opened by Minister for Trade, Mr Simon Crean, in a ceremony held earlier today.
“This facility is a great success story and we are helping Australian companies like Parnell to fight above their weight in export markets," said Mr Crean at the opening.
-
UniQuest brokers international biofuel partnership
-
Apollo develops needle-free topical vaccine
-
Study reveals link between tea and rheumatoid arthritis
-
Halcygen (ASX:HGN) to expand board following departure of director and COO
-
AstraZeneca invests in Victoria's NeuProtect
-
Fluorescence Applications in Biotechnology and Life Sciences
-
Molecular & Cell Biology for Dummies
-
Writing Scientific Research Articles - Strategy and Steps
-
Introduction to Statistics for Forensic Scientists
-
An Introduction to Molecular Biotechnology - Molecular Fundamentals, Methods and Applications in Modern Biotechnology
-
Dictionary of DNA and Genome Technology 2E
-
The Scientific American a Day in the Life of Your Brain
-
Statistics for Terrified Biologists
-
Proteins - Structure and Function



Comments
Post new comment